Summary

● The company has poor fundamentals for a short-term investment strategy.


Strengths

● Its core activity has a significant growth potential and sales are expected to surge, according to Thomson Reuters' forecast. Indeed, those may increase by 49% by 2021.

● The company shows low valuation levels, with an enterprise value at 0.55 times its sales.


Weaknesses

● The stock is close to a major daily resistance at EUR 132.2, which should be gotten rid of so as to gain new appreciation potential.

● The company sustains low margins.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.

● The three month average target prices set by analysts do not offer high potential in comparison with the current prices.